Protocol Design Featured Articles
-
What Does It Mean To Be "Underserved"?
1/8/2025
Learn what makes someone "underserved," understand the importance of that person's participation in research, learn about the barriers to them doing so, and discover ways to improve their inclusion.
-
7 Most Talked About Factors To Transform Clinical Trials
1/3/2025
Ivanna Rosendal, global head of digitalization at Ascendis Pharma, shares the seven things guests on her podcast "Transformation in Trials" think will transform clinical trials.
-
How AI Will Transform Health Equity In Clinical Trials In 2025
12/23/2024
Click Therapeutics' CMO/CSO Shaheen Lakhan, MD, Ph.D., FAAN explains how the shift toward AI is the first step in addressing diversity in clinical trials.
-
What Future Laboratory Manuals Should Look Like
12/20/2024
In the final article of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair imagines what the perfect lab manual might look like — and how to make it a reality.
-
How Laboratory Manuals Fail Sites And Sponsors
12/19/2024
In part one of this series, FlexPoint Bio Founder and CEO Elena Sinclair describes the hazards of poorly designed (and followed) clinical trial lab manuals.
-
Lab Manual Gaps: Sabotaging Data One Sample At A Time
12/19/2024
In part two of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair discusses the criticality of sample and process quality.
-
BeiGene Details Its Approach To Expanding Oncology Trials Into Brazil
12/17/2024
In this second article, BeiGene's Lígia Campos details its journey to setting roots in Brazil, sharing its beginnings there and highlighting its approach to study start-up and patient recruitment and enrollment.
-
BeiGene Explains The Landscape Of Oncology Trials In Brazil
12/16/2024
In part one of this two-part series, BeiGene's Brazil and LATAM clinical operations head Lígia Campos details Brazil's cancer treatment landscape and the benefits of expanding oncology trials there.
-
I AM INCLUDED: 8 Best Practices For Sites To Drive More Inclusive Clinical Trials
12/13/2024
Discover the I AM INCLUDED framework, along with the actionable practices it provides to help all types of clinical trial sites extend the reach of their research.
-
What's Needed To Transform Clinical Trials In Early-Stage Prostate Cancer
12/9/2024
President and CEO of Candel Therapeutics Paul Peter Tak, MD, Ph.D., FMedSci calls for changes in early-stage prostate cancer clinical trials, from biomarkers to endpoints to technology.